Literature DB >> 21972386

Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure.

Delphine Natali1, Barbara Girerd1, David Montani1, Florent Soubrier2, Gérald Simonneau1, Marc Humbert1, Olivier Sitbon3.   

Abstract

We report a case of pulmonary arterial hypertension (PAH) occurring in a patient with Cowden syndrome with a mutation in the phosphatase and tensin (PTEN) tumor suppressor gene, in the context of exposure to the appetite suppressant dexfenfluramine. Anorexigen exposure is known to be a risk factor for PAH. However, the role of PTEN in cell function and the development of pulmonary vascular remodeling and histopathologic signs of PAH in mice with a Pten depletion in smooth muscle cells suggest that the association of PAH and Cowden syndrome may be relevant. In this case report, we hypothesize that PTEN mutations may be a predisposing factor for the development of PAH, with anorexigen exposure as a potential trigger.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972386     DOI: 10.1378/chest.10-2588

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Pulmonary arterial hypertension in a patient with Cowden syndrome and the PTEN mutation.

Authors:  Duc Ha; Jessica Mester; Charis Eng; Samar Farha
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

2.  Pulmonary hypertension secondary to left-heart failure involves peroxynitrite-induced downregulation of PTEN in the lung.

Authors:  Yazhini Ravi; Karuppaiyah Selvendiran; Shan K Naidu; Sarath Meduru; Lucas A Citro; Balázs Bognár; Mahmood Khan; Tamás Kálai; Kálmán Hideg; Periannan Kuppusamy; Chittoor B Sai-Sudhakar
Journal:  Hypertension       Date:  2013-01-21       Impact factor: 10.190

3.  Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertension.

Authors:  Henrick Horita; Seth B Furgeson; Allison Ostriker; Kyle A Olszewski; Timothy Sullivan; Leah R Villegas; Michelle Levine; Jane E Parr; Carlyne D Cool; Raphael A Nemenoff; Mary C M Weiser-Evans
Journal:  J Am Heart Assoc       Date:  2013-05-31       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.